Schnoy E, Dignass A, Gaskins M, Kucharzik T, et al. From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis. Z Gastroenterol 2025 Jun 16. doi: 10.1055/a-2596-8934.
PMID: 40523395